Back to search

University of Alabama Birmingham

Integrated Proteomics To Understand The Role Of Neuritin-1 (Nrn1) As A Molecular Mediator Of Synaptic Resilience In Alzheimer’S Disease

Abstract

dc:description.abstract

Alzheimer’s disease (AD) is the leading cause of dementia in adults over the age of 65, and currently affects approximately 6.9 million people in the United States. By 2060, the number of people age 65 and older with AD is projected to reach 13.8 million, barring the development of disease-altering therapies to prevent, slow or cure AD. Thus, there is a need for progress in the understanding of AD pathophysiology, as well as in the development of diagnostic and therapeutic interventions. Approximately one-third of individuals without dementia at the time of death are found to harbor high levels of amyloid-beta (Aβ) and tau neurofibrillary tangle (NFT) pathology. Individuals that evade cognitive de-cline despite high levels of Aβ and NFT pathology appear to exhibit cognitive resilience to the clinical manifestations of AD. Dendritic spine loss correlates more strongly with cognitive impairment than AD neuropathology. Dendritic spine plasticity is hypothesized to be a mechanism of cognitive resilience that protects individuals with moderate to severe AD neuropathology from developing dementia. It is therefore important to identify genes and proteins that mediate cognitive resilience in order to understand the relation-ship between dendritic spine loss and cognitive impairment in AD. Here, we implemented an integrative mass spectrometry (MS)-based proteomic strategy across distinct stages of AD to prioritize protein modules linked to resilience. Computational strategies identified Neuritin-1 (NRN1) as a top candidate of resilience in a module associated with synaptic biology. The established link between synaptic loss and cognitive impairment in AD and the predominance of synaptic proteins in our top resilience-associated modules, warrants examining the impact of NRN1 on synaptic integrity and maintenance as foundational to determining NRN1’s role in resilience. To validate the computational analysis, primary cultured neurons were used to evaluate the neuroprotective mechanisms of NRN1 against Aβ. To advance the investigation of NRN1 as a therapeutic target candidate for AD, we characterized commercially available polyclonal NRN1 antibodies using in vitro and in vivo models systems as well as postmortem human brain tissue samples. This work furthers our understanding of NRN1 as a molecular mediator of cognitive resilience to AD neuropathology.

Degree

thesis:*
Name thesis:degree_name
Doctor of Philosophy (PhD)
Level thesis:degree_level
Dissertation
Discipline thesis:degree_discipline
Joint Health Sciences

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Pugh, Derian
Contributors dc:contributor
  • <p>Jeremy Herskowitz</p>
  • <p>Ashley Harms<br>Briana De Miranda<br>Erik Roberson<br>Jeremy Day</p>

Subjects

dc:subject × 5

Identifiers

dc:identifier.*
Repository record dc:identifier
https://digitalcommons.library.uab.edu/etd-2020s/72

Chain of custody

source
Harvested from
University of Alabama Birmingham
Base URL
digitalcommons.library.uab.edu/do/oai/
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

Pugh, Derian. Integrated Proteomics To Understand The Role Of Neuritin-1 (Nrn1) As A Molecular Mediator Of Synaptic Resilience In Alzheimer’S Disease. Dissertation thesis, https://digitalcommons.library.uab.edu/etd-2020s/72